These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5898035)

  • 1. [Insulin resistance. IV. Breaking through insulin intolerance with alpha-methyldopa].
    Meythaler F; Kotlorz H
    Arztl Forsch; 1965 Aug; 19(8):433-46. PubMed ID: 5898035
    [No Abstract]   [Full Text] [Related]  

  • 2. [BREAKING THE INSULIN IN RESISTANCE WITH ALPHA-METHYLDOPA].
    MEYTHALER F; WEILER K
    Klin Wochenschr; 1964 Jun; 42():590-2. PubMed ID: 14236989
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
    del Greco F; Huang CM; Quintanilla A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study.
    Flaa A; Aksnes TA; Kjeldsen SE; Eide I; Rostrup M
    Metabolism; 2008 Oct; 57(10):1422-7. PubMed ID: 18803948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyldopa in the elderly hypertensive.
    MacFarlane JP
    Curr Med Res Opin; 1982; 7(Suppl 1):63-7. PubMed ID: 7049582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isocarboxazide as an antagonist of the hypotensive effect of alpha-methyldopa].
    Tolva D; Benati E; Colombo G
    Policlinico Prat; 1966 Feb; 73(9):293-9. PubMed ID: 5932989
    [No Abstract]   [Full Text] [Related]  

  • 7. [The combined use of alpha-methyldopa and butizide in the treatment of arterial hypertension].
    Gobbi A; Reguzzoni G; Bonzi G
    Clin Ter; 1981 May; 97(3):283-90. PubMed ID: 7285534
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of antihypertensive treatment with alpha-methyldopa in patients with arterial hypertension and diabetes mellitus].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Scapellato L
    Clin Ter; 1982 May; 101(3):257-65. PubMed ID: 7094550
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].
    Beretta R; Cassi E; Colombo A; De Paoli A; Marciandi C; Renzetti GA
    Clin Ter; 1982 Dec; 103(5):487-500. PubMed ID: 7160141
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
    Reynisdottir S; Ellerfeldt K; Wahrenberg H; Lithell H; Arner P
    J Clin Invest; 1994 Jun; 93(6):2590-9. PubMed ID: 8200997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arterial hypertension with an alpha-methyldopa-hydrochlorothiazide combination].
    Tourniaire A; Blum J; Hutinel P; Gallet M
    Presse Med (1893); 1966 Jun; 74(30):1601-2. PubMed ID: 5932443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with alpha-methyldopa (Aldomet) in the office treatment of hypertension].
    Merki W
    Schweiz Med Wochenschr; 1966 Jan; 96(1):25-6. PubMed ID: 5983491
    [No Abstract]   [Full Text] [Related]  

  • 15. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in selected indicators of platelet function in patients with primary arterial hypertension treated with alpha-methyldopa].
    Wysokiński A; Florkiewicz H; Markiewicz M; Kowalewski J
    Pol Tyg Lek; 1984 Dec; 39(50):1661-3. PubMed ID: 6527966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of alpha-methyldopa on myometrial noradrenaline release and myometrial contractility in rat.
    Csonka D; Zupkó I; Minorics R; Márki A; Csík G; Falkay G
    Acta Obstet Gynecol Scand; 2007; 86(8):986-94. PubMed ID: 17653886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
    Goldberg MR; Tung CS; Feldman RD; Smith HE; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1982 Mar; 220(3):552-60. PubMed ID: 7062266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin on endothelial and contractile function of subcutaneous small resistance arteries of hypertensive and diabetic patients.
    De Ciuceis C; Rizzoni D; Porteri E; Boari GE; Zani F; Miclini M; Tiberio GA; Giulini SM; Paiardi S; Rizzardi N; Platto C; Agabiti-Rosei E
    J Vasc Res; 2008; 45(6):512-20. PubMed ID: 18451634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.